Recent Posts

webinar, on-demand webinar, precision oncology, cancer
The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology
Posted 14th March 2023

The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology

Read More
webinar , on-demand webinar , precision oncology , cancer
The time has come to change the way we treat cancer
Posted 7th March 2023

The time has come to change the way we treat cancer

Read More
Blog , case study , webinar
Webinar highlights of 2021
Posted 15th December 2021

Webinar highlights of 2021

Read More
1
webinar , on-demand webinar , precision oncology , cancer
The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology
Posted 14th March 2023

The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology

Read More
webinar , on-demand webinar , precision oncology , cancer
The time has come to change the way we treat cancer
Posted March Mar 7th 2023

The time has come to change the way we treat cancer

Read More
Blog , case study , webinar
Webinar highlights of 2021
Posted December Dec 15th 2021

Webinar highlights of 2021

Read More
1
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.